Broadly neutralizing and protective nanobodies against diverse sarbecoviruses
Abstract As SARS-CoV-2 Omicron and other variants of concern continue spreading around the world, development of antibodies and vaccines to confer broad and protective activity is a global priority. Here, we report on the identification of a special group of nanobodies from immunized alpaca with exceptional breadth and potency against diverse sarbecoviruses including SARS-CoV-1, Omicron BA.1, and BA.2. Crystal structure analysis of one representative nanobody, 3-2A2-4, revealed a highly conserved epitope between the cryptic and the outer face of the receptor binding domain (RBD). The epitope is readily accessible regardless of RBD in “up” or “down” conformation and distinctive from the receptor ACE2 binding site. Passive delivery of 3-2A2-4 protected K18-hACE2 mice from infection of authentic SARS-CoV-2 Delta and Omicron. This group of nanobodies and the epitope identified should provide invaluable reference for the development of next generation antibody therapies and vaccines against wide varieties of SARS-CoV-2 infection and beyond..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
bioRxiv.org - (2022) vom: 16. Apr. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Li, Mingxi [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| doi: |
10.1101/2022.04.12.488087 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI035761172 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI035761172 | ||
| 003 | DE-627 | ||
| 005 | 20230429093032.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220415s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2022.04.12.488087 |2 doi | |
| 035 | |a (DE-627)XBI035761172 | ||
| 035 | |a (biorXiv)10.1101/2022.04.12.488087 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Li, Mingxi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Broadly neutralizing and protective nanobodies against diverse sarbecoviruses |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract As SARS-CoV-2 Omicron and other variants of concern continue spreading around the world, development of antibodies and vaccines to confer broad and protective activity is a global priority. Here, we report on the identification of a special group of nanobodies from immunized alpaca with exceptional breadth and potency against diverse sarbecoviruses including SARS-CoV-1, Omicron BA.1, and BA.2. Crystal structure analysis of one representative nanobody, 3-2A2-4, revealed a highly conserved epitope between the cryptic and the outer face of the receptor binding domain (RBD). The epitope is readily accessible regardless of RBD in “up” or “down” conformation and distinctive from the receptor ACE2 binding site. Passive delivery of 3-2A2-4 protected K18-hACE2 mice from infection of authentic SARS-CoV-2 Delta and Omicron. This group of nanobodies and the epitope identified should provide invaluable reference for the development of next generation antibody therapies and vaccines against wide varieties of SARS-CoV-2 infection and beyond. | ||
| 700 | 1 | |a Ren, Yifei |e verfasserin |4 aut | |
| 700 | 1 | |a Aw, Zhen Qin |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Bo |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Ziqing |e verfasserin |4 aut | |
| 700 | 1 | |a Lei, Yuqing |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Lin |e verfasserin |4 aut | |
| 700 | 1 | |a Liang, Qingtai |e verfasserin |4 aut | |
| 700 | 1 | |a Hong, Junxian |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Yiling |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Yi Hao |e verfasserin |4 aut | |
| 700 | 1 | |a Shan, Sisi |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Senyan |e verfasserin |4 aut | |
| 700 | 1 | |a Ge, Jiwan |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Ruoke |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Xuanling |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Qi |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Zheng |e verfasserin |4 aut | |
| 700 | 1 | |a Chu, Justin Jang Hann |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Xinquan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Linqi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2022) vom: 16. Apr. |
| 773 | 1 | 8 | |g year:2022 |g day:16 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2022.04.12.488087 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 16 |c 04 | ||
| 953 | |2 045F |a 570 | ||